New biomarker predicts preeclampsia, fetal growth issues in first trimester

Researchers publishing in Nature Medicine identified Isthmin-2, a protein, as an early biomarker for preeclampsia and fetal growth restriction. The study, involving 6,000 pregnant individuals, found higher Isthmin-2 levels at 11-13 weeks could predict these complications.